Treatment of HCV disorders

Details for Australian Patent Application No. 2010201591 (hide)

Owner Novartis AG

Inventors Brinkmann, Volker; Feutren, Gilles

Agent Davies Collison Cave

Pub. Number AU-A-2010201591

Parent 2006204524

Filing date 21 April 2010

Wipo publication date 13 May 2010

International Classifications

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61K 31/661 (2006.01) - Phosphorus acids or esters thereof not having PC bonds, e.g. fosfosal, dichlorvos, malathion

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

13 May 2010 Application Open to Public Inspection

  Published as AU-A-2010201591

13 May 2010 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010201592-Methods for identifying functionally related genes and drug targets

2010201590-Reduction of antimicrobial compound levels during product dispensing